| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-08 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |